COLOWELL^® Noninvasive Colorectal Cancer Screening Test

COLOWELL^® is a non-invasive early-stage screening product for colorectal cancer developed by Realbio Medical for many years. Due to the rapid renewal of intestinal epithelial cells, it renews once every 3 to 4 days. The detached colorectal epithelial cells are excreted with the stool. Analysis of DNA fragments of tumor cells in stool can detect precancerous lesions and colorectal cancer 5 to 6 years in advance. The test results are accurate. Detailed test reports and personalized health recommendations are issued to provide early warning of colorectal cancer.

UTWELL^TM Detection of DNA methylation in bladder cancer

UTWELL^TM is a product for detection that identifies the risk of suffering from bladder cancer and monitors the risk of postoperative recurrence of bladder cancer by finding the apparent genetics changes of specific genes in the urine of the tested population. It is a non-invasive gene detection method that takes the urine tumor exfoliated cells as samples.

Technology Service

Realbio Technology Co. Ltd., is a company that provides professional gene technology and health service, is committed to providing customers with the highest quality products and services. Providing scientific research services to universities, research institutions, and hospitals, including 16S/ITS amplicons sequencing, metagenomic sequencing, meta-virus sequencing, metatranscriptome sequencing, bacterial genome sequencing, multi-omics analysis, and bioinformatic analysis, etc. We have published many articles in microbial research, metabolomics research, tumor mechanism research, and other fields.